Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang, Hengyou Weng, Jianjun Chen
Cancer Cell (2020) Vol. 37, Iss. 3, pp. 270-288
Open Access | Times Cited: 889

Showing 26-50 of 889 citing articles:

The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 136
N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer
Shiyan Wang, Shanshan Gao, Yong Zeng, et al.
Gastroenterology (2021) Vol. 162, Iss. 4, pp. 1183-1196
Open Access | Times Cited: 131
Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 131
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
Jianwei Qu, Haimeng Yan, Yifan Hou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 127
Circ0008399 Interaction with WTAP Promotes Assembly and Activity of the m6A Methyltransferase Complex and Promotes Cisplatin Resistance in Bladder Cancer
Wenjie Wei, Jiayin Sun, Hui Zhang, et al.
Cancer Research (2021) Vol. 81, Iss. 24, pp. 6142-6156
Open Access | Times Cited: 126
FTO in cancer: functions, molecular mechanisms, and therapeutic implications
Yangchan Li, Rui Su, Xiaolan Deng, et al.
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 598-614
Open Access | Times Cited: 118
JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA
Zegui Ni, Pengli Sun, Jin Hai Zheng, et al.
Cancer Research (2022) Vol. 82, Iss. 9, pp. 1789-1802
Open Access | Times Cited: 117
Roles of RNA Methylation on Tumor Immunity and Clinical Implications
Maorun Zhang, Junmin Song, Weitang Yuan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 116
m6A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilization
Chuandong Lang, Chi Yin, Kai‐Yuan Lin, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 6
Open Access | Times Cited: 116
WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis
Zhi‐Xuan Li, Zi‐Qi Zheng, Pan-Yang Yang, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1137-1151
Open Access | Times Cited: 116
RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma
Yuanbo Cui, Chunyan Zhang, Shanshan Ma, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 108
METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification
Yiming Xu, Dandan Lv, Chao Yan, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 108
LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC
Xinyi Qian, Juze Yang, Qiongzi Qiu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 107
Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts
Ting Li, Yue‐Tao Tan, Yan‐Xing Chen, et al.
Gut (2022) Vol. 72, Iss. 3, pp. 501-511
Open Access | Times Cited: 107
Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis
Yan‐Hong Cui, Seungwon Yang, Jiangbo Wei, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 102
LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Yihao Liu, Minmin Shi, Xingfeng He, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 102
NAT10‐mediated mRNA N4‐acetylcytidine modification promotes bladder cancer progression
Ganping Wang, Ming Zhang, Yiming Zhang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 95
RNA m6A regulates transcription via DNA demethylation and chromatin accessibility
Shuang Deng, Jialiang Zhang, Jiachun Su, et al.
Nature Genetics (2022) Vol. 54, Iss. 9, pp. 1427-1437
Closed Access | Times Cited: 90
The roles and mechanism of m6A RNA methylation regulators in cancer immunity
Lu Chen, Ying He, Jinyu Zhu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114839-114839
Open Access | Times Cited: 89
WTAP-mediated m6A modification of lncRNA NORAD promotes intervertebral disc degeneration
Gaocai Li, Liang Ma, Shujie He, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner
Yun-zhang Dai, Yong-da Liu, Jie Li, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 83
The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability
Nan Zhang, Yan Shen, Huan Li, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 2, pp. 194-205
Open Access | Times Cited: 80
Exon junction complex shapes the m6A epitranscriptome
Xin Yang, Robinson Triboulet, Qi Liu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
Hengyu Chen, Yuanhang Yu, Ming Yang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 75
FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner
Feihong Ji, Xing-Hao Fu, Guoquan Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 74

Scroll to top